Gaido Health
Manhattan Beach, California, USA
Acquired, was Takeda Pharmaceuticals' oncology digital therapeutics platform.
How We Help
Problem Statement
Disconnected oncology care pathways lead to challenges in monitoring post-discharge patients, increasing hospital readmissions, and limiting patients' ability to self-manage symptoms.
Core Technology
Proprietary machine learning and AI-based algorithms for continuous patient monitoring and early complication detection, combining vital signs from remote monitoring (including Biofourmis's Everion wearable biosensor), patient surveys, and analytics.
Key Differentiators
Enabled clinicians to quickly triage and efficiently follow up with high-risk patients by detecting early signs of complications, addressing disconnected oncology care, and empowering patients with AI-based symptom management.
Clinical Focus
Oncology, specifically remote patient monitoring for cancer patients after hospital discharge.
Target Customers
Healthcare providers, hospitals, and health systems managing oncology patients, particularly post-discharge.
Product Stage
GA
Company Info
- Business Model
- B2B SaaS, providing a remote monitoring platform to healthcare providers and health systems.
- Founded
- 2018
Categories
Disease Areas
Technologies
MedStartr Index Score
?What do you think of Gaido Health?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.